Id |
Subject |
Object |
Predicate |
Lexical cue |
TextSentencer_T1 |
0-96 |
Sentence |
denotes |
Placenta-derived, cellular messenger RNA expression in the maternal blood of preeclamptic women. |
T1 |
0-96 |
Sentence |
denotes |
Placenta-derived, cellular messenger RNA expression in the maternal blood of preeclamptic women. |
TextSentencer_T2 |
97-107 |
Sentence |
denotes |
OBJECTIVE: |
T2 |
97-107 |
Sentence |
denotes |
OBJECTIVE: |
TextSentencer_T3 |
108-327 |
Sentence |
denotes |
To perform gene expression profiling and real-time quantitative reverse-transcription polymerase chain reaction (PCR) analysis to identify biomarkers of preeclampsia in cellular messenger RNA (mRNA) from maternal blood. |
T3 |
108-327 |
Sentence |
denotes |
To perform gene expression profiling and real-time quantitative reverse-transcription polymerase chain reaction (PCR) analysis to identify biomarkers of preeclampsia in cellular messenger RNA (mRNA) from maternal blood. |
TextSentencer_T4 |
328-336 |
Sentence |
denotes |
METHODS: |
T4 |
328-336 |
Sentence |
denotes |
METHODS: |
TextSentencer_T5 |
337-468 |
Sentence |
denotes |
We performed a microarray analysis with five maternal blood samples from women with preeclampsia and five matched control subjects. |
T5 |
337-468 |
Sentence |
denotes |
We performed a microarray analysis with five maternal blood samples from women with preeclampsia and five matched control subjects. |
TextSentencer_T6 |
469-650 |
Sentence |
denotes |
Up-regulated gene expression was further analyzed through reverse-transcription PCR analysis with 28 consecutive blood samples from women affected with preeclampsia and 29 controls. |
T6 |
469-650 |
Sentence |
denotes |
Up-regulated gene expression was further analyzed through reverse-transcription PCR analysis with 28 consecutive blood samples from women affected with preeclampsia and 29 controls. |
TextSentencer_T7 |
651-659 |
Sentence |
denotes |
RESULTS: |
T7 |
651-659 |
Sentence |
denotes |
RESULTS: |
TextSentencer_T8 |
660-775 |
Sentence |
denotes |
Both pregnancy-specific beta1 glycoprotein and trophoblast glycoprotein were selected based on microarray analysis. |
T8 |
660-775 |
Sentence |
denotes |
Both pregnancy-specific beta1 glycoprotein and trophoblast glycoprotein were selected based on microarray analysis. |
TextSentencer_T9 |
776-902 |
Sentence |
denotes |
Reverse-transcription PCR analysis detected significantly increased mRNA concentrations among women in the preeclampsia group. |
T9 |
776-902 |
Sentence |
denotes |
Reverse-transcription PCR analysis detected significantly increased mRNA concentrations among women in the preeclampsia group. |
TextSentencer_T10 |
903-1129 |
Sentence |
denotes |
When stratified according to mild or severe preeclampsia, 19.2-fold and 41.8-fold increases in pregnancy-specific beta1 glycoprotein and 8.3-fold and 10.6-fold increases in trophoblast glycoprotein were observed, respectively. |
T10 |
903-1129 |
Sentence |
denotes |
When stratified according to mild or severe preeclampsia, 19.2-fold and 41.8-fold increases in pregnancy-specific beta1 glycoprotein and 8.3-fold and 10.6-fold increases in trophoblast glycoprotein were observed, respectively. |
TextSentencer_T11 |
1130-1347 |
Sentence |
denotes |
Among women with hemolysis, elevated liver enzymes, and low platelet count syndrome, 51.6-fold and 13.1-fold increases in pregnancy-specific beta1 glycoprotein and trophoblast glycoprotein were observed, respectively. |
T11 |
1130-1347 |
Sentence |
denotes |
Among women with hemolysis, elevated liver enzymes, and low platelet count syndrome, 51.6-fold and 13.1-fold increases in pregnancy-specific beta1 glycoprotein and trophoblast glycoprotein were observed, respectively. |
TextSentencer_T12 |
1348-1498 |
Sentence |
denotes |
In the preeclampsia group, pregnancy-specific beta1 glycoprotein correlated with severity of proteinuria (P<.001) and systolic blood pressure (P=.01). |
T12 |
1348-1498 |
Sentence |
denotes |
In the preeclampsia group, pregnancy-specific beta1 glycoprotein correlated with severity of proteinuria (P<.001) and systolic blood pressure (P=.01). |
TextSentencer_T13 |
1499-1510 |
Sentence |
denotes |
CONCLUSION: |
T13 |
1499-1510 |
Sentence |
denotes |
CONCLUSION: |
TextSentencer_T14 |
1511-1802 |
Sentence |
denotes |
The mRNA expression of pregnancy-specific beta1 glycoprotein and trophoblast glycoprotein is up-regulated in cells circulating within blood from women with preeclampsia, and pregnancy-specific beta1 glycoprotein expression is positively correlated with the clinical severity of preeclampsia. |
T14 |
1511-1802 |
Sentence |
denotes |
The mRNA expression of pregnancy-specific beta1 glycoprotein and trophoblast glycoprotein is up-regulated in cells circulating within blood from women with preeclampsia, and pregnancy-specific beta1 glycoprotein expression is positively correlated with the clinical severity of preeclampsia. |
TextSentencer_T15 |
1803-1825 |
Sentence |
denotes |
LEVEL OF EVIDENCE: II. |
T15 |
1803-1825 |
Sentence |
denotes |
LEVEL OF EVIDENCE: II. |